261 related articles for article (PubMed ID: 31927053)
1. A transnosographic approach of negative symptoms pathophysiology in schizophrenia and depressive disorders.
Guessoum SB; Le Strat Y; Dubertret C; Mallet J
Prog Neuropsychopharmacol Biol Psychiatry; 2020 Apr; 99():109862. PubMed ID: 31927053
[TBL] [Abstract][Full Text] [Related]
2. [Negative Symptoms in Schizophrenia - an Overview].
Klaus F; Kaiser S; Kirschner M
Ther Umsch; 2018 Jun; 75(1):51-56. PubMed ID: 29909762
[TBL] [Abstract][Full Text] [Related]
3. Neurophysiological correlates of Avolition-apathy in schizophrenia: A resting-EEG microstates study.
Giordano GM; Koenig T; Mucci A; Vignapiano A; Amodio A; Di Lorenzo G; Siracusano A; Bellomo A; Altamura M; Monteleone P; Pompili M; Galderisi S; Maj M;
Neuroimage Clin; 2018; 20():627-636. PubMed ID: 30202724
[TBL] [Abstract][Full Text] [Related]
4. Individual negative symptoms and domains - Relevance for assessment, pathomechanisms and treatment.
Kaiser S; Lyne J; Agartz I; Clarke M; Mørch-Johnsen L; Faerden A
Schizophr Res; 2017 Aug; 186():39-45. PubMed ID: 27453425
[TBL] [Abstract][Full Text] [Related]
5. Positive Emotions Program for Schizophrenia (PEPS): a pilot intervention to reduce anhedonia and apathy.
Favrod J; Nguyen A; Fankhauser C; Ismailaj A; Hasler JD; Ringuet A; Rexhaj S; Bonsack C
BMC Psychiatry; 2015 Sep; 15():231. PubMed ID: 26419356
[TBL] [Abstract][Full Text] [Related]
6. Deconstructing Negative Symptoms in Individuals at Clinical High-Risk for Psychosis: Evidence for Volitional and Diminished Emotionality Subgroups That Predict Clinical Presentation and Functional Outcome.
Gupta T; Cowan HR; Strauss GP; Walker EF; Mittal VA
Schizophr Bull; 2021 Jan; 47(1):54-63. PubMed ID: 32955097
[TBL] [Abstract][Full Text] [Related]
7. Network Analysis Reveals the Latent Structure of Negative Symptoms in Schizophrenia.
Strauss GP; Esfahlani FZ; Galderisi S; Mucci A; Rossi A; Bucci P; Rocca P; Maj M; Kirkpatrick B; Ruiz I; Sayama H
Schizophr Bull; 2019 Sep; 45(5):1033-1041. PubMed ID: 30256991
[TBL] [Abstract][Full Text] [Related]
8. Mapping anhedonia-specific dysfunction in a transdiagnostic approach: an ALE meta-analysis.
Zhang B; Lin P; Shi H; Öngür D; Auerbach RP; Wang X; Yao S; Wang X
Brain Imaging Behav; 2016 Sep; 10(3):920-39. PubMed ID: 26487590
[TBL] [Abstract][Full Text] [Related]
9. Pathophysiology of negative symptom dimensions of schizophrenia - Current developments and implications for treatment.
Bègue I; Kaiser S; Kirschner M
Neurosci Biobehav Rev; 2020 Sep; 116():74-88. PubMed ID: 32533996
[TBL] [Abstract][Full Text] [Related]
10. Self-evaluation of negative symptoms in adolescent and young adult first psychiatric episodes.
Mallet J; Guessoum SB; Tebeka S; Le Strat Y; Dubertret C
Prog Neuropsychopharmacol Biol Psychiatry; 2020 Dec; 103():109988. PubMed ID: 32474008
[TBL] [Abstract][Full Text] [Related]
11. Dopamine dysregulation hypothesis: the common basis for motivational anhedonia in major depressive disorder and schizophrenia?
Szczypiński JJ; Gola M
Rev Neurosci; 2018 Sep; 29(7):727-744. PubMed ID: 29573379
[TBL] [Abstract][Full Text] [Related]
12. Ventral striatal hypoactivation is associated with apathy but not diminished expression in patients with schizophrenia.
Kirschner M; Hager OM; Bischof M; Hartmann MN; Kluge A; Seifritz E; Tobler PN; Kaiser S
J Psychiatry Neurosci; 2016 Apr; 41(3):152-61. PubMed ID: 26395814
[TBL] [Abstract][Full Text] [Related]
13. Acute and chronic effects of NMDA receptor antagonists in rodents, relevance to negative symptoms of schizophrenia: a translational link to humans.
Neill JC; Harte MK; Haddad PM; Lydall ES; Dwyer DM
Eur Neuropsychopharmacol; 2014 May; 24(5):822-35. PubMed ID: 24287012
[TBL] [Abstract][Full Text] [Related]
14. Range-Adaptive Value Representation in Different Stages of Schizophrenia: A Proof of Concept Study.
Wang LL; Lam CYT; Huang J; Cheung EFC; Lui SSY; Chan RCK
Schizophr Bull; 2021 Oct; 47(6):1524-1533. PubMed ID: 34420057
[TBL] [Abstract][Full Text] [Related]
15. Network Analysis Reveals Which Negative Symptom Domains Are Most Central in Schizophrenia vs Bipolar Disorder.
Strauss GP; Esfahlani FZ; Kirkpatrick B; Allen DN; Gold JM; Visser KF; Sayama H
Schizophr Bull; 2019 Oct; 45(6):1319-1330. PubMed ID: 30649527
[TBL] [Abstract][Full Text] [Related]
16. Negative symptoms: A review of schizophrenia, melancholic depression and Parkinson's disease.
Winograd-Gurvich C; Fitzgerald PB; Georgiou-Karistianis N; Bradshaw JL; White OB
Brain Res Bull; 2006 Oct; 70(4-6):312-21. PubMed ID: 17027767
[TBL] [Abstract][Full Text] [Related]
17. Developing concepts in negative symptoms: primary vs secondary and apathy vs expression.
Kirkpatrick B
J Clin Psychiatry; 2014; 75 Suppl 1():3-7. PubMed ID: 24581452
[TBL] [Abstract][Full Text] [Related]
18. An active inference perspective on the negative symptoms of schizophrenia.
Jeganathan J; Breakspear M
Lancet Psychiatry; 2021 Aug; 8(8):732-738. PubMed ID: 33865502
[TBL] [Abstract][Full Text] [Related]
19. [The clinic of apathy in schizophrenia: a critical review of the issue].
Yazbek H; Raffard S; Del-Monte J; Pupier F; Larue A; Boulenger JP; Gély-Nargeot MC; Capdevielle D
Encephale; 2014 Jun; 40(3):231-9. PubMed ID: 23958346
[TBL] [Abstract][Full Text] [Related]
20. Two and five-factor models of negative symptoms in schizophrenia are differentially associated with trait affect, defeatist performance beliefs, and psychosocial functioning.
Paul NB; Strauss GP; Gates-Woodyatt JJ; Barchard KA; Allen DN
Eur Arch Psychiatry Clin Neurosci; 2023 Dec; 273(8):1715-1724. PubMed ID: 36633673
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
